Fish Collagen Peptides - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The fish collagen peptides market size is projected to be USD 396.72 million in 2025, USD 443.49 million in 2026, and reach USD 774.29 million by 2031, growing at a CAGR of 11.79% from 2026 to 2031. This report is Segmented by Source (Fish Skin, Fish Scales, Fish Bones, Fish Fins, and Others), Form (Powder Liquid, Capsules and Tablets, and Others), Application (Dietary Supplements, Pharmaceuticals, Food and Beverages, and More), Distribution Channel (B2B and Industrial Sales, Online Retail, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Value (USD).

Global Fish Collagen Peptides Market Trends and Insights

Rising Demand for Beauty From Within Nutricosmetics

The fish collagen peptides market is seeing demand shift from bulk ingredient trade toward premium ingestible beauty formats that are sold on clinical positioning, ingredient traceability, and finished-product claims. Buyers in this category increasingly look for species provenance and molecular weight information, which supports fish-derived Type I collagen over less transparent alternatives. This shift is also changing the route to market because dermatology clinics in Japan and South Korea are directing patients toward fish collagen peptide regimens paired with hyaluronic acid, which gives the category a practitioner-backed route rather than a simple shelf presence. Clinical supplementation studies over 8 to 12 weeks linked daily fish collagen intake with better skin hydration, improved elasticity, and reduced wrinkle appearance, which gives branded products the evidence base needed for premium pricing. The fish collagen peptides market, therefore, gains not only volume from beauty demand but also stronger margins because brands with medical affairs, formulation depth, and claim support can separate themselves from generic suppliers.

Superior Bioavailability Versus Mammalian Collagen

The fish collagen peptides market continues to benefit from the smaller peptide size achieved through enzymatic hydrolysis, which supports faster passage through the intestinal barrier and better systemic availability. Fish collagen peptides are produced in the 3 to 10 kDa range, while native bovine collagen chains sit much higher, which helps explain why marine collagen is often positioned on absorption and usability grounds. Reviews cited in the source material indicate marine collagen can reach up to 1.5 times the absorption efficiency of bovine collagen at equal dosing, which keeps the efficacy narrative favorable for premium fish-derived products. An important commercial effect is that suppliers can focus differentiation on religious compliance, pescatarian fit, and cleaner label positioning without needing to give up performance-based messaging. In regulated markets, access to human clinical data is also becoming more important because health-claim rules shape what can be said on labels and what B2B buyers are willing to pay for validated ingredients. The fish collagen peptides market is therefore gaining from a mix of physiological performance, formulation flexibility, and regulatory alignment rather than from a single clinical argument alone.

Limited and Seasonal Marine Raw Material Supply

The fish collagen peptides market remains exposed to seasonal catch patterns, species-specific yield swings, and the limited geographic concentration of large fish processing hubs. Pollock, cod, tilapia, and salmon are among the major collagen-yielding species, so weather shocks, quota changes, overfishing controls, or disease outbreaks can move quickly into raw material prices. Supply is also pressured by competing uses for the same by-products because fishmeal, fish oil, and biogas operators are also investing in recovery capacity. Weishardt renewed Friend of the Sea certification for its Naticol marine collagen brand in December 2024, which shows that even established players face growing compliance expectations around traceable and legally sourced marine inputs. Norwegian fisheries research also pointed to dried and salted cod skins as an underused but promising collagen source, which suggests the fish collagen peptides market still has room to reduce supply risk if more by-product streams are commercialized. Even so, supply limitations continue to cap how quickly the fish collagen peptides market can scale in premium and regulated applications.

Other drivers and restraints analyzed in the detailed report include:

• Expansion of Halal, Kosher, and Pescatarian Formulations
• Circular Economy Use of Seafood By-Products
• Higher Cost of Extraction and Purification Versus Bovine Alternatives

Segment Analysis

Fish skin held 58.23% of the fish collagen peptides market share in 2025, making it the most established raw material source within the fish collagen peptides market. Its position reflects mature extraction protocols, broad commercial familiarity, and a strong clinical link with skin-health formulations that already have traction in supplements and beauty products. In 2026, fish skin continues to benefit from integrated processing systems in large tilapia and pollock hubs, which helps suppliers maintain quality control and output scale. Solubility performance and cleaner purification pathways also make fish skin more attractive for finished-goods manufacturers that need dependable ingredient behavior across formats. These advantages keep fish skin at the center of mainstream supply in the fish collagen industry, especially where large-volume supplements and beauty formulations depend on reliable sourcing.

Fish scales are projected to grow at a 12.45% CAGR through 2031, showing that the segment is moving from an underused by-product to a stronger commercial source in the fish collagen peptides market. Recovery technologies are improving, and ultrasound-coupled natural deep eutectic solvent methods are now supporting native Type I collagen extraction from discarded seabass scales with competitive yields and lower solvent waste. This matters because scale material is abundant and was historically overlooked despite its dense collagen content. Fish bones still contribute meaningful volume in pharmaceutical-grade products because hydroxyapatite co-extraction supports dual positioning for bone-health formulas. Fish fins and the others category, including swim bladders, cartilage, and heads, remain niche but are drawing research attention as medical and technical applications broaden. Commercial growth in those smaller categories will still depend on better scale-up economics and more consistent collagen quality across batches.

Powder held 60.56% share in 2025, showing that the fish collagen peptides market still leans heavily on ingredient trade and scalable dry formats. Powder remains attractive because it fits high-volume hydrolysis output, stores well, and moves easily into capsules, sachets, and functional food systems without heavy downstream handling. These characteristics keep it central to B2B supply and explain why large manufacturers continue to rely on powder for mainstream wellness and beauty positioning. The format also supports cost discipline because it limits packaging complexity and aligns well with industrial blending operations. For these reasons, powder remains the volume anchor even as the fish collagen peptides market moves toward more differentiated delivery systems.

Liquid is projected to expand at a 14.93% CAGR through 2031, and this makes it one of the clearest premiumization channels in the fish collagen peptides market. The source material notes that liquid collagen products can command retail premiums of 3 times to 5 times versus equivalent powder dosing, which reflects the higher perceived convenience and efficacy of ready-to-drink formats. A 2026 clinical study on hydrolyzed collagen from sea bass skin showed measurable gains in hydration, roughness, and elasticity after 30 days, which supports liquid collagen as a clinically credible delivery method. Capsules and tablets continue to serve pharmacy and clinical nutrition channels, where standardized dosing remains important for practitioner recommendation and repeat use. The others category, which includes gummies, films, and hydrogels, is still smaller but is moving quickly because easier dosing can improve acceptance among pediatric and older users. As consumer products become more brand-driven, the fish collagen peptides market size for liquid and other convenient formats is likely to rise faster than bulk dry powder demand.

Complete Report Scope:

• By Source
  • Fish Skin
  • Fish Scales
  • Fish Bones
  • Fish Fins
  • Others
• By Form
  • Powder
  • Liquid
  • Capsules and Tablets
  • Others
• By Application
  • Dietary Supplements
  • Pharmaceuticals
  • Food and Beverages
  • Cosmetics and Personal Care
  • Others
• By Distribution Channel
  • B2B and Industrial Sales
  • Online Retail
  • Pharmacies and Drug Stores
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 38.47% of the fish collagen peptides market share in 2025, which made it the largest regional contributor within the fish collagen peptides market. The region benefits from a well-capitalized supplement manufacturing base, high health and wellness spending, and a strong direct-to-consumer ecosystem for collagen products. The United States remains the largest national market and is also distinct because demand extends beyond supplements into wound care, hospital supply, and medical device pathways. Clinical interest in acellular fish skin grafts for diabetic wounds and venous leg ulcers supports this broader use profile in 2026. Canada adds volume through natural health products, while Mexico supports demand through food processing applications. Europe remains important because the marine ingredient manufacturing strength in France and Germany supports both product development and regulatory positioning. Copalis SEA continues to valorize Atlantic catch by-products into branded marine ingredients, which keeps Europe relevant in premium collagen supply.

Asia-Pacific is projected to grow at a 17.62% CAGR through 2031, giving it the fastest regional expansion in the fish collagen peptides market. The region combines unmatched supply potential with rising consumer demand, which few other regions can replicate at the same time. China generates large volumes of collagen-rich by-products through fish processing, and Hainan Huayan’s Haikou facility has become a major export-oriented production base with 9,000 metric tons of annual capacity across 2 lines. Japan remains one of the most demanding fish collagen peptides markets because companies such as Nippi and Nitta Gelatin compete on patented compositions, anti-doping certification, and premium clinical positioning. South Korea, India, and Australia add further momentum through beauty supplements, dietary supplements, and functional foods, which helps keep regional growth above the global average.

The Middle East and Africa and South America still represent smaller shares, but both carry strategic relevance for future expansion in the fish collagen peptides market. In the Gulf states, halal certification is moving from a premium feature toward a category requirement for wider supplement distribution. Saudi Arabia’s domestic pharmaceutical investment is beginning to create downstream demand for pharmaceutical-grade collagen inputs, while South Africa serves as a distribution gateway for parts of sub-Saharan Africa. In South America, Brazil’s cosmetics manufacturing base and Argentina’s nutraceutical development create early-stage volume opportunities, while wider supplier coverage from global collagen producers should improve access over time. These regions are still smaller today, but certification, pharmaceutical expansion, and regional supply coverage can gradually raise their role in the fish collagen peptides market.

List of Companies Covered in this Report:

• BioCell Technology LLC
• Copalis SEA
• Gelita
• Hainan Huayan Collagen Biotech Co., Ltd.
• Hainan Xiangtai Fishery Biotechnology Co., Ltd.
• Hangzhou Nutrition Biotechnology Co., Ltd.
• Hofseth BioCare ASA
• Nippi Inc.
• Nitta Gelatin Inc.
• Norland Products Inc.
• PB Leiner (Tessenderlo Group)
• Qingdao Wanli Marine Biotechnology Co., Ltd.
• Rousselot (Darling Ingredients)
• Seagarden AS
• Shanghai Tong-Ji Biotechnology Co., Ltd.
• Shenzhen Taier Biotechnology Co., Ltd.
• SOPROPECHE
• Weishardt Group
• Xiamen Yiyu Biological Technology Co., Ltd.
• Yichang Shanchengshuidu Biotechnology Co., Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support